Related Experiment Video
Updated: Feb 13, 2026

Use of Frozen Tissue in the Comet Assay for the Evaluation of DNA Damage
Published on: March 24, 2020
An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage
Gamze Kuser-Abali1, Lu Gong1, Jiawei Yan1
1John B. Little Center for Radiation Sciences, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
Abstract:
Renewable tissues exhibit heightened sensitivity to DNA damage, which is thought to result from a high level of p53. However, cell proliferation in renewable tissues requires p53 down-regulation, creating an apparent discrepancy between the p53 level and elevated sensitivity to DNA damage. Using a combination of genetic mouse models and pharmacologic inhibitors, we demonstrate that it is p53-regulated MDM2 that functions together with MDMX to regulate DNA damage sensitivity by targeting EZH2 (enhancer of zeste homolog 2) for ubiquitination/degradation. As a methyltransferase, EZH2 promotes H3K27me3, and therefore chromatin compaction, to determine sensitivity to DNA damage. We demonstrate that genetic and pharmacologic interference of the association between MDM2 and MDMX stabilizes EZH2, resulting in protection of renewable tissues from radio-/chemotherapy-induced acute injury. In cells with p53 mutation, there are diminished MDM2 levels, and thus accumulation of EZH2, underpinning the resistant phenotype. Our work uncovers an epigenetic mechanism behind tissue sensitivity to DNA damage, carrying important translation implications.
Insights
Renewable tissues
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Renewable tissues are sensitive to DNA damage, potentially due to high p53 levels.
- Cell proliferation necessitates p53 down-regulation, creating a paradox in DNA damage sensitivity.
- Understanding this discrepancy is crucial for protecting tissues during cancer therapy.
Purpose of the Study:
- To investigate the epigenetic mechanism regulating DNA damage sensitivity in renewable tissues.
- To identify the role of p53, MDM2, MDMX, and EZH2 in this process.
- To explore therapeutic strategies for protecting tissues from genotoxic stress.
Main Methods:
- Utilized genetic mouse models and pharmacologic inhibitors.
- Investigated the interaction between MDM2, MDMX, and EZH2.
- Assessed the impact of EZH2 on chromatin compaction (H3K27me3) and DNA damage sensitivity.
- Examined p53-mutated cells to understand resistance mechanisms.
Main Results:
- p53-regulated MDM2, with MDMX, targets EZH2 for degradation, controlling DNA damage sensitivity.
- EZH2, a methyltransferase, promotes H3K27me3 and chromatin compaction, influencing DNA damage response.
- Inhibiting the MDM2-MDMX interaction stabilizes EZH2, protecting tissues from radio-/chemotherapy injury.
- Diminished MDM2 in p53-mutated cells leads to EZH2 accumulation and treatment resistance.
Conclusions:
- Uncovered an epigenetic mechanism involving EZH2 in tissue sensitivity to DNA damage.
- MDM2-MDMX-EZH2 axis regulates chromatin compaction and DNA damage response.
- Targeting this axis offers a potential strategy to protect renewable tissues during cancer therapy.
- Findings have significant translational implications for improving cancer treatment outcomes.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...

